Cyendiv 100 Mg

Cyendiv 100 Mg

Cyendiv 100 Mg (Nintedanib) is is an anti-cancer, a Soft Gelatin Capsule, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer.. It blocks the action of the abnormal protein which signals cancer cells to multiply and thereby prevents spread of cancer cells.

Drug = Nintedanib

Strength = 100 Mg

Manufacturer = Boehringer Ingelheim

How To Take

Take Cyendiv 100 Mg in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.

Dosage

Cyendiv 100 Mg

Cyendiv 150 Mg

Side Effects

Diarrhea

Nausea

Vomiting

Weight loss

Severe stomach pain

Coughing up blood

Dizziness

Headache

Irregular heartbeat

Nosebleed

Constipation

Dry skin

Hair loss

Slow heart beat

Unusual tiredness or weakness

Warning

Alcohol:-There is no data available. Please consult doctor before consuming the drug.

Pregnancy:- Cyendiv 100 Mg Soft Gelatin Capsule is unsafe to use during pregnancy.

There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Driving:- Do not drive unless you are feeling well.You may feel sick after taking this medicine and this could affect your driving.

Kidney:- Cyendiv 100 Mg Soft Gelatin Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Cyendiv 100 Mg Soft Gelatin Capsule may be needed. Please consult your doctor.

There is limited information available on the use of Cyendiv 100 Mg Soft Gelatin Capsule in these patients.

Liver:- Cyendiv 100 Mg Soft Gelatin Capsule should be used with caution in patients with liver disease. Dose adjustment of Cyendiv 100 Mg Soft Gelatin Capsule may be needed. Please consult your doctor.

Use of Cyendiv 100 Mg Soft Gelatin Capsule is not recommended in patients with moderate to severe liver disease.

Uses

Cyendiv 100 Mg  used in Idiopathic pulmonary fibrosis. Non-small cell lung cancer.